Quality of Life and Performance Status From a Substudy Conducted Within a Prospective Phase 3 Randomized Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Locally Advanced Head and Neck Carcinoma: NRG Oncology Radiation Therapy Oncology Group 0522.
International Journal of Radiation Oncology Biology Physics.
Times cited: 5
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival.
The lancet oncology.
Times cited: 1005
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
New England Journal of Medicine.
Times cited: 3149